ÂÜÀòÂÒÂ×

Patrick Murphy serves as Vice President and Head of Regulatory Affairs at Apellis Pharmaceuticals, where responsibilities include leading global regulatory programs for chronic local portfolios since November 2019. Previously, at Orexigen Therapeutics, Patrick held the position of Senior Director, overseeing international regulatory affairs across diverse markets and managing submission activities. Prior experience includes directing regulatory affairs at Prothena Biosciences Limited, focusing on EU regulatory strategy, and acting as Head of Global Regulatory Affairs at IQVIA. Patrick's extensive regulatory experience is supported by an MSc in Pharmaceutical Medicine from Trinity College Dublin and a BSc in Chemistry, Pharmaceutical Chemistry, and Biology from Maynooth University.